Comprehensive risk assessments of diabetic patients from seven Asian countries: The Joint Asia Diabetes Evaluation (JADE) program

Background:  The aim of the web‐based Joint Asia Diabetes Evaluation (JADE) program is to establish a registry for quality assurance, monitoring, and evaluation. Methods:  The JADE electronic portal provides templates for data collection, supplemented by risk stratification, care protocols, and deci...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes 2011-06, Vol.3 (2), p.109-118
Main Authors: SO, Wing-Yee, RABOCA, Josephine, SOBREPENA, Leorino, YOON, Kun-Ho, DEEROCHANAWONG, Chaicharn, HO, Low-Tone, HIMATHONGKAM, Thep, TONG, Peter, LYUBOMIRSKY, Greg, KO, Gary, NAN, Hairong, CHAN, Juliana
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Aged, 80 and over
Asia
Asia - epidemiology
care models
Cohort Studies
diabetes
Diabetes Complications - diagnosis
Diabetes Complications - epidemiology
Diabetes Complications - therapy
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - therapy
disease management
Female
Humans
Internet
Male
Middle Aged
quality of care
Registries
risk assessment
Risk Factors
Urban Population
Young Adult
Citations: Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background:  The aim of the web‐based Joint Asia Diabetes Evaluation (JADE) program is to establish a registry for quality assurance, monitoring, and evaluation. Methods:  The JADE electronic portal provides templates for data collection, supplemented by risk stratification, care protocols, and decision support. Herein, data from 3687 patients with Type 2 diabetes, enrolled over 15 months in 2007–2009 from seven Asian countries, are reported. Results:  Of the patients, 46.1% were men, the median (range) age was 58 (15–93 years), and median disease duration was 6.5 (0–71) years; 16.2% had at least one cardiovascular–renal complication (10.0% coronary heart disease, 3.3% stroke, 3.1% peripheral vascular disease, 0.4% end‐stage renal disease), 20.4% had diabetic retinopathy, 15.0% had sensory neuropathy, 7.5% had chronic kidney disease, and 20.7% of men had erectile dysfunction. Hypertension, dyslipidemia, and central obesity affected 84.6%, 76.8%, and 53.5% of patients, respectively. Treatment targets were HbA1c
ISSN:1753-0393
1753-0407
DOI:10.1111/j.1753-0407.2011.00115.x